Charles River Laboratories Total Long Term Liabilities 2010-2024 | CRL

Charles River Laboratories total long term liabilities from 2010 to 2024. Total long term liabilities can be defined as the sum of all non-current liabilities.
  • Charles River Laboratories total long term liabilities for the quarter ending September 30, 2024 were $3.204B, a 2.97% decline year-over-year.
  • Charles River Laboratories total long term liabilities for 2023 were $3.538B, a 0.21% increase from 2022.
  • Charles River Laboratories total long term liabilities for 2022 were $3.53B, a 2.26% increase from 2021.
  • Charles River Laboratories total long term liabilities for 2021 were $3.452B, a 36.29% increase from 2020.
Charles River Laboratories Annual Total Long Term Liabilities
(Millions of US $)
2023 $3,538
2022 $3,530
2021 $3,452
2020 $2,533
2019 $2,345
2018 $1,978
2017 $1,419
2016 $1,443
2015 $1,019
2014 $900
2013 $742
2012 $641
2011 $814
2010 $785
2009 $580
Charles River Laboratories Quarterly Total Long Term Liabilities
(Millions of US $)
2024-09-30 $3,204
2024-06-30 $3,274
2024-03-31 $3,552
2023-12-31 $3,538
2023-09-30 $3,302
2023-06-30 $3,507
2023-03-31 $3,604
2022-12-31 $3,530
2022-09-30 $3,736
2022-06-30 $3,828
2022-03-31 $3,466
2021-12-31 $3,452
2021-09-30 $3,643
2021-06-30 $3,467
2021-03-31 $2,817
2020-12-31 $2,533
2020-09-30 $2,525
2020-06-30 $2,756
2020-03-31 $2,855
2019-12-31 $2,345
2019-09-30 $2,365
2019-06-30 $2,532
2019-03-31 $1,996
2018-12-31 $1,978
2018-09-30 $2,000
2018-06-30 $2,163
2018-03-31 $1,451
2017-12-31 $1,419
2017-09-30 $1,425
2017-06-30 $1,383
2017-03-31 $1,435
2016-12-31 $1,443
2016-09-30 $1,405
2016-06-30 $1,513
2016-03-31 $1,009
2015-12-31 $1,019
2015-09-30 $1,010
2015-06-30 $904
2015-03-31 $909
2014-12-31 $900
2014-09-30 $885
2014-06-30 $917
2014-03-31 $714
2013-12-31 $742
2013-09-30 $749
2013-06-30 $745
2013-03-31 $642
2012-12-31 $641
2012-09-30 $642
2012-06-30 $653
2012-03-31 $777
2011-12-31 $814
2011-09-30 $820
2011-06-30 $838
2011-03-31 $872
2010-12-31 $785
2010-09-30 $805
2010-06-30 $517
2010-03-31 $556
2009-12-31 $580
2009-09-30 $588
2009-06-30 $601
2009-03-31 $590
Sector Industry Market Cap Revenue
Medical Medical Services $9.516B $4.129B
Charles River Laboratories International, Inc. is a full service, early-stage contract research organization. The company provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions globally accelerate their research and drug development efforts. The company has a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP. This helps support its clients from target identification through non-clinical development. Charles River also provides a line of products and services to support clients' manufacturing activities. Utilizing the company's broad portfolio of products and services, clients can create a more flexible drug development model, aiming cost reduction, productivity enhancement and increase in speed to market. Charles River currently has three reporting segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA) and Manufacturing Support.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $91.424B 11.34
Cencora (COR) United States $47.484B 17.51
DiDi Global (DIDIY) China $23.330B 0.00
Natera (NTRA) United States $21.401B 0.00
ICON (ICLR) Ireland $16.136B 14.37
Viatris (VTRS) United States $15.576B 4.80
Avantor (AVTR) United States $13.422B 20.12
Revvity (RVTY) United States $13.376B 23.24
CochLear (CHEOY) Australia $12.844B 0.00
BioMerieux (BMXMF) France $12.666B 0.00
Solventum (SOLV) United States $11.583B 0.00
Medpace Holdings (MEDP) United States $9.789B 27.58
Doximity (DOCS) United States $9.620B 56.63
HealthEquity (HQY) United States $8.966B 48.66
Sonic Healthcare (SKHHY) Australia $8.758B 0.00
Bausch + Lomb (BLCO) Canada $6.885B 32.05
Life Times (LTH) United States $5.085B 33.66
Sotera Health (SHC) United States $3.855B 20.62
Organon (OGN) United States $3.757B 3.79
BrightSpring Health Services (BTSG) United States $3.247B 69.07
Surgery Partners (SGRY) United States $2.892B 32.97
PACS (PACS) United States $2.606B 0.00
Concentras Parent (CON) United States $2.581B 0.00
Ardent Health Partners (ARDT) United States $2.375B 0.00
Premier (PINC) United States $2.143B 11.15
Alignment Healthcare (ALHC) United States $2.126B 0.00
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
GeneDx Holdings (WGS) United States $1.952B 0.00
GoodRx Holdings (GDRX) United States $1.616B 42.40
Teladoc Health (TDOC) United States $1.537B 0.00
Pediatrix Medical (MD) United States $1.255B 12.28
CareDx (CDNA) United States $1.183B 0.00
Progyny (PGNY) United States $1.164B 23.57
Establishment Labs Holdings (ESTA) $1.050B 0.00
AMN Healthcare Services Inc (AMN) United States $0.954B 6.46
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
Embecta (EMBC) United States $0.778B 5.18
SBC Medicals (SBC) United States $0.677B 0.00
Agilon Health (AGL) United States $0.655B 0.00
InnovAge Holding (INNV) United States $0.647B 0.00
Auna S.A (AUNA) Luxembourg $0.536B 0.00
Sonida Senior Living (SNDA) United States $0.425B 0.00
DocGo (DCGO) United States $0.410B 15.46
Enhabit (EHAB) United States $0.366B 31.61
COMPASS Pathways (CMPS) United Kingdom $0.326B 0.00
LifeMD (LFMD) United States $0.241B 0.00
ModivCare (MODV) United States $0.223B 12.09
Sera Prognostics (SERA) United States $0.209B 0.00
Beauty Health (SKIN) United States $0.200B 0.00
Biodesix (BDSX) United States $0.180B 0.00
Nutex Health (NUTX) United States $0.156B 0.00
Ascend Wellness Holdings (AAWH) United States $0.100B 0.00
So-Young (SY) China $0.092B 22.25
MultiPlan (MPLN) United States $0.084B 0.00
Singular Genomics Systems (OMIC) United States $0.054B 0.00
OncoCyte (OCX) United States $0.043B 0.00
NeueHealth (NEUE) United States $0.041B 1.08
Co-Diagnostics (CODX) United States $0.034B 0.00
Pheton Holdings (PTHL) China $0.030B 0.00
IceCure Medical (ICCM) Israel $0.028B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.020B 0.00
Oncology Institute (TOI) United States $0.014B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
XWELL (XWEL) United States $0.008B 0.00
Intelligent Bio Solutions (INBS) United States $0.006B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00